
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.27 | -9.03010033445 | 2.99 | 3.25 | 2.7 | 4306 | 3.10191578 | CS |
4 | -0.18 | -6.20689655172 | 2.9 | 3.2999 | 2.7 | 5313 | 3.1192077 | CS |
12 | -0.65 | -19.2878338279 | 3.37 | 3.5 | 2.2 | 8157 | 2.82926333 | CS |
26 | -1.29 | -32.1695760599 | 4.01 | 4.34 | 2.2 | 7553 | 3.41263092 | CS |
52 | -1.07 | -28.2321899736 | 3.79 | 5.2 | 2.2 | 13269 | 3.81608841 | CS |
156 | -4.08 | -60 | 6.8 | 10 | 2.2 | 24439 | 4.90806289 | CS |
260 | -11.08 | -80.2898550725 | 13.8 | 58.5 | 2.2 | 801233 | 28.58045139 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions